These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 14739767)
1. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Siwik DA; Colucci WS Heart Fail Rev; 2004 Jan; 9(1):43-51. PubMed ID: 14739767 [TBL] [Abstract][Full Text] [Related]
2. Alcohol modulation of cardiac matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs favors collagen accumulation. El Hajj EC; El Hajj MC; Voloshenyuk TG; Mouton AJ; Khoutorova E; Molina PE; Gilpin NW; Gardner JD Alcohol Clin Exp Res; 2014 Feb; 38(2):448-56. PubMed ID: 24033327 [TBL] [Abstract][Full Text] [Related]
3. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Pauschinger M; Chandrasekharan K; Schultheiss HP Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765 [TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy]. Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome. Meiners S; Hocher B; Weller A; Laule M; Stangl V; Guenther C; Godes M; Mrozikiewicz A; Baumann G; Stangl K Hypertension; 2004 Oct; 44(4):471-7. PubMed ID: 15337735 [TBL] [Abstract][Full Text] [Related]
7. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Li YY; McTiernan CF; Feldman AM Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and left ventricular remodelling after myocardial infarction. Hori M; Nishida K Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340 [TBL] [Abstract][Full Text] [Related]
9. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support. Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334 [TBL] [Abstract][Full Text] [Related]
10. Age- and gender-dependent myocardial transcription patterns of cytokines and extracellular matrix remodelling enzymes in cats with non-cardiac diseases. Fonfara S; Hetzel U; Hahn S; Kipar A Exp Gerontol; 2015 Dec; 72():117-23. PubMed ID: 26429336 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Spinale FG Circ Res; 2002 Mar; 90(5):520-30. PubMed ID: 11909815 [TBL] [Abstract][Full Text] [Related]
12. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction. Cleutjens JP; Creemers EE J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143 [TBL] [Abstract][Full Text] [Related]
13. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells. Zhou G; Peng F; Zhong Y; Chen Y; Tang M; Li D Int J Oncol; 2017 Mar; 50(3):933-941. PubMed ID: 28098862 [TBL] [Abstract][Full Text] [Related]
14. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. Uchida M; Shima M; Shimoaka T; Fujieda A; Obara K; Suzuki H; Nagai Y; Ikeda T; Yamato H; Kawaguchi H J Cell Physiol; 2000 Nov; 185(2):207-14. PubMed ID: 11025442 [TBL] [Abstract][Full Text] [Related]
15. The effects of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and transforming growth factor-beta1 on pulp fibroblast mediated collagen degradation. Wisithphrom K; Windsor LJ J Endod; 2006 Sep; 32(9):853-61. PubMed ID: 16934628 [TBL] [Abstract][Full Text] [Related]
16. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069 [TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223 [TBL] [Abstract][Full Text] [Related]
19. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243 [TBL] [Abstract][Full Text] [Related]
20. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Braundmeier AG; Nowak RA Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]